2-112779564-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_000575.5(IL1A):āc.422A>Gā(p.Asn141Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000887 in 1,611,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000575.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL1A | NM_000575.5 | c.422A>G | p.Asn141Ser | missense_variant | 5/7 | ENST00000263339.4 | |
IL1A | NM_001371554.1 | c.422A>G | p.Asn141Ser | missense_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL1A | ENST00000263339.4 | c.422A>G | p.Asn141Ser | missense_variant | 5/7 | 1 | NM_000575.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251272Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135800
GnomAD4 exome AF: 0.0000836 AC: 122AN: 1459658Hom.: 0 Cov.: 30 AF XY: 0.0000812 AC XY: 59AN XY: 726216
GnomAD4 genome AF: 0.000138 AC: 21AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2022 | The c.422A>G (p.N141S) alteration is located in exon 5 (coding exon 4) of the IL1A gene. This alteration results from a A to G substitution at nucleotide position 422, causing the asparagine (N) at amino acid position 141 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at